| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Institute of Immunological Science, Hokkaido University, Kita-ku, Sapporo 060
and2 Department of Microbiology, Osaka Medical College, Takatsuki, Osaka 567, Japan
Under conditions in which a clonal cell line (M10) isolated from a human T cell lymphotrophic virus type I-transformed MT-4 cell line was completely killed by infection with wild-type human immunodeficiency virus type 1 (HIV-1), equivalent M10 cells survived infection with HIV-1 vif, vpr or vpu mutant virus after transient cytopathic effects. Several cell clones, which were isolated from the proliferating M10 cells after infection with vif and vpu mutant viruses (M10/vif- and M10/vpu-), had heterogeneous HIV-1 phenotypes in terms of HIV-1 antigen expression, their syncytium forming capacity, reverse transcriptase activity and the infectivity of HIV-1 particles produced. When the replication kinetics of the HIV-1 particles produced were assayed in M10 cells, the clones could be classified into three types, i.e. type I producing non-infectious HIV-1, type II producing infectious HIV-1 with low replicative ability and type III producing infectious HIV-1 with a replicative ability similar to that of wild-type HIV-1. HIV-1 major viral cell proteins and virus particle fractions were almost typical in types II and III but not in type I. Electron microscopic examination of particles released by I, II and III clones revealed rare defective, predominantly defective and essentially normal virions, respectively. Northern and Southern blot analyses revealed no apparent deletion in the proviral DNA and mRNA prepared from these clones, except in the case of type I and II clones isolated from M10/vpu- which contained large deletions in the mRNAs for gag and gag-pol proteins. Thus, M10 cells surviving infection with HIV-1 vif or vpu mutants are heterogeneous, persistently expressing HIV-1 antigens and producing non-infectious or less cytopathic virus.
Received 14 May 1991;
accepted 23 September 1991.
This article has been cited by other articles:
|
|
 |
|
  S. Kao, M. A. Khan, E. Miyagi, R. Plishka, A. Buckler-White, and K. Strebel The Human Immunodeficiency Virus Type 1 Vif Protein Reduces Intracellular Expression and Inhibits Packaging of APOBEC3G (CEM15), a Cellular Inhibitor of Virus Infectivity J. Virol., November 1, 2003; 77(21): 11398 - 11407. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Komoto, S. Tsuji, M. S. Ibrahim, Y.-G. Li, J. Warachit, K. Taniguchi, and K. Ikuta The Vpu Protein of Human Immunodeficiency Virus Type 1 Plays a Protective Role against Virus-Induced Apoptosis in Primary CD4+ T Lymphocytes J. Virol., October 1, 2003; 77(19): 10304 - 10313. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Drakulovski, B. Carcy, K. Moubri, C. Carret, D. Depoix, T. P. M. Schetters, and A. Gorenflot Antibodies Raised against Bcvir15, an Extrachromosomal Double-Stranded RNA-Encoded Protein from Babesia canis, Inhibit the In Vitro Growth of the Parasite Infect. Immun., March 1, 2003; 71(3): 1056 - 1067. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kao, H. Akari, M. A. Khan, M. Dettenhofer, X.-F. Yu, and K. Strebel Human Immunodeficiency Virus Type 1 Vif Is Efficiently Packaged into Virions during Productive but Not Chronic Infection J. Virol., December 20, 2002; 77(2): 1131 - 1140. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Khan, H. Akari, S. Kao, C. Aberham, D. Davis, A. Buckler-White, and K. Strebel Intravirion Processing of the Human Immunodeficiency Virus Type 1 Vif Protein by the Viral Protease May Be Correlated with Vif Function J. Virol., August 12, 2002; 76(18): 9112 - 9123. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Khan, C. Aberham, S. Kao, H. Akari, R. Gorelick, S. Bour, and K. Strebel Human Immunodeficiency Virus Type 1 Vif Protein Is Packaged into the Nucleoprotein Complex through an Interaction with Viral Genomic RNA J. Virol., August 15, 2001; 75(16): 7252 - 7265. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Ikuta, S. Suzuki, H. Horikoshi, T. Mukai, and R. B. Luftig Positive and Negative Aspects of the Human Immunodeficiency Virus Protease: Development of Inhibitors versus Its Role in AIDS Pathogenesis Microbiol. Mol. Biol. Rev., December 1, 2000; 64(4): 725 - 745. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. E. Sutton, H. T. M. Wu, R. Rigg, E. Bohnlein, and P. O. Brown Human Immunodeficiency Virus Type 1 Vectors Efficiently Transduce Human Hematopoietic Stem Cells J. Virol., July 1, 1998; 72(7): 5781 - 5788. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K Fujinaga, T Nakaya, and K Ikuta Generation of endogenous tumour necrosis factor-alpha in MOLT-4 cells during the acute replication phase of human immunodeficiency virus type 1 determines the subsequent latent infection J. Gen. Virol., February 1, 1998; 79(2): 221 - 229. [Abstract]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
